HopeStage
Back to all studies
CompletedNCT00757029

Genetic factors in methylphenidate response for ADHD

About this titleRead the official source — NCT00757029
Interventional studyAges 6–18South Korea
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 18 years.

Listed locations
Anyang-siSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2005
Recruitment status
Completed
Enrollment listed in the registry
150
Sponsor
Hallym University Medical Center
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
GENETIC
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
South Korea
Age range
From 6 Years to 18 Years
Official registry ID
NCT00757029
Official title
Show the full official title

Association Between Norepinephrine Transporter Polymorphism and Response of Methylphenidate

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Anyang-si

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hallym University Medical Center, a hospital or academic medical center.

Who was this study for?

Listed age limits: 6 years to 18 years.

Want to explore more studies?

Explore studies